Source: Annual Congress 2006 - Noninvasive mechanical ventilation in acute and chronic respiratory failure – a broad field
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
S. Avdeev, X. Popova, G. Nekludova, A. Chuchalin (Moscow, Russian Federation). Effect of noninvasive ventilation (NIV) on left ventricular (LV) function, B-type natriuretic peptide (BNP) and markers of systemic inflammation in patients with refractory heart failure. Eur Respir J 2006; 28: Suppl. 50, 1145

Member's Comments

No comment yet.

Related content which might interest you: Brain natriuretic peptide (BNP) and right ventricular dysfunction predict survival in interstitial lung disease (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Effect of continuous positive airway pressure on plasma B-type natriuretic peptide in patients with respiratory failure and left ventricular dysfunction complicating acute myocardial infarction Source: Annual Congress 2006 - Acute respiratory failure: diagnostic procedures and clinical management Year: 2006 Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 B-type natriuretic peptide (BNP) in COPD patients with acute respiratory failure (ARF) Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Echocardiography and N-terminal-pro-brain natriuretic peptide in assessment of left ventricular diastolic dysfunction in stable COPD in relation to disease severity Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 The relationship between pro-BNP(brain natriuretic peptide), c-reactive protein(CRP) and right ventricular dysfunction in pulmonary embolism Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 Effect of auto servo-ventilation (ASV) and continuous positive airway pressure (CPAP) on B-type natriuretic peptide (NT-proBNP) in patients with co-existing obstructive (OSA) and central sleep apnea (CSA) in heart failure (HF) Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 The application of B-type natriuretic peptide level of the dyspneic patients ; differentiation between cor pulmonale and left ventricular dysfunction Source: Eur Respir J 2003; 22: Suppl. 45, 583s Year: 2003 Identification of left ventricular systolic dysfunction or pulmonary hypertension in patients with asthma or chronic obstructive pulmonary disease by N-terminal pro-brain natriuretic peptide Source: Annual Congress 2007 - New insight into the pathophysiology of asthma Year: 2007 Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension? Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007 Presence of inspiratory crackles (IC) in stable chronic obstructive pulmonary disease (COPD) patients; correlation with plasma N-terminal pro-brain natriuretic peptide (NT-BNP) levels Source: Annual Congress 2008 - Assessment of the respiratory system Year: 2008 Usefulness of serum (S) and pleural fluid (PF) levels of pro-brain natriuretic peptide (Pro-BNP) in the diagnosis of pleural transudates due to congestive heart failure (CHF) Source: Eur Respir J 2006; 28: Suppl. 50, 581s Year: 2006 NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension Source: Eur Respir J 2007; 29: 737-744 Year: 2007 N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2003 Oct 01;22(4):649-653 Year: 2003 Non-invasive parameters can predict out of proportion pulmonary hypertension (PH) in conjunction with heart failure and preserved systolic function (HFPSF) in patients with moderate to severe PH Source: Annual Congress 2010 - Pulmonary hypertension updates Year: 2010 N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patient with acute exacerbations (AE) of COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Atrial natriuretic peptide as a serum marker of right atrial enlargement and function in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Determination of B-type natriuretic peptide in patients with chronic heart failure and Cheyne-Stokes respiration Source: Eur Respir J 2004; 24: Suppl. 48, 563s Year: 2004 Right ventricular diastolic function in patients with COPD and heart failure, depending on endothelial function Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013 Brain natriuretic peptide (BNP) determination in patients hospitalized for COPD exacerbation Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008